Cargando…
Prophylactic urethral stenting with Memokath(®) 028SW in prostate cancer patients undergoing prostate (125)I seed implants: phase I/II study
PURPOSE: To study the feasibility/toxicity of urethral stenting with the Memokath(®) 028SW stent in patients undergoing prostate implant (PI) for prostate adenocarcinoma. MATERIAL AND METHODS: An Investigational Device Exemption from the Food and Drug Administration (FDA) and institutional review bo...
Autores principales: | Chao, Samuel T., Angermeier, Kenneth, Klein, Eric A., Reddy, Chandana A., Ulchaker, James C., Stephenson, Andrew, Campbell, Steven, Ciezki, Jay P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108832/ https://www.ncbi.nlm.nih.gov/pubmed/27877196 http://dx.doi.org/10.5114/jcb.2011.21038 |
Ejemplares similares
-
Use of the Memokath Urethral Stent in the management of ileal conduit stomal stenosis
por: Pan, Tzong-Yang, et al.
Publicado: (2015) -
Long-term result of Memokath urethral sphincter stent in spinal cord injury patients
por: Vaidyanathan, Subramanian, et al.
Publicado: (2002) -
Early Experience With a Thermo-Expandable Stent (Memokath) for the Management of Recurrent Urethral Stricture
por: Jung, Hyun Su, et al.
Publicado: (2013) -
Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer
por: Hunter, Grant K., et al.
Publicado: (2012) -
Bladder Neck Contracture after Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia Treated with a Thermo-Expandable Metal Stent (Memokath® 045)
por: Wen, Jan, et al.
Publicado: (2018)